Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Characterisation and Identification of Cell Engulfment Receptors on cDC1s.

Project description

Unravelling phagocytosis in dendritic cells

Dendritic cells are key immune cells capable of recognising, processing and presenting antigens to coordinate immunity or maintain self-tolerance. Type 1 conventional dendritic cells (cDC1s) are essential for triggering immune responses against infections and tumours because of their unique ability to engulf dying cells. With the support of the Marie Skłodowska-Curie Actions programme, the CICERO_cDC1 project will study how these cells recognise and internalise dead cells. Researchers will integrate a variety of technologies to find the receptors involved in the uptake of apoptotic cells. To find the receptors involved in the uptake of apoptotic cells, researchers will integrate a variety of technologies. The research will shed light on phagocytosis in dendritic cells and open the door to new strategies to enhance anti-tumour immunity.

Objective

The engulfment of dead cells by type 1 conventional dendritic cells (cDC1s) is essential to maintain tolerance to self-antigens and to induce immunity to infected or malignant cells. cDC1s have the unique ability to engulf dead cells, in contrast to the closely related cDC2s. Moreover, uptake of apoptotic cells induces cDC1 maturation and serves as their key source of antigens. However, we still do not understand which receptors on cDC1s are involved in the recognition and internalisation of dead cell corpses and whether these receptors differ depending on the type of cell death (e.g. apoptosis vs necrosis) that led to corpse formation. Remarkably, our preliminary data indicates that cDC1s, unlike macrophages, 1) do not express many of the classical or canonical engulfment receptors, 2) they tend to nibble pieces from dead cells and 3) are able to ingest parts of live cells. Hence, in the proposed work, I aim to characterise live, apoptotic and necrotic cell engulfment by cDC1s and its phosphatidylserine-dependency using novel reagents and state-of-the-art instrumentation such as high-resolution live cell microscopy. Furthermore, I will use a validated CRISPR-editing protocol and establish a CRISPR screen with both primary and immortalized cDC1 cell lines to discover which receptors on cDC1s are necessary for the engulfment of live, apoptotic and/or necrotic cells. Lastly, I will interrogate in vivo the role of key cDC1-dependent phagocytic receptors in a tumour and tolerance model using novel markers for DC maturation that I identified during my PhD. Altogether, the work in this proposal will elucidate a long-standing question in the DC and phagocytosis field, contribute to our knowledge on how cDC1s mediate anti-tumour immunity and tolerance, and may open new strategies to improve anti-tumour immunity and tolerance to self.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

THE FRANCIS CRICK INSTITUTE LIMITED
Net EU contribution
€ 276 187,92
Address
1 MIDLAND ROAD
NW1 1AT London
United Kingdom
Region
London Inner London — West Camden and City of London
Activity type
Research Organisations
Links
Total cost
No data